Evidence map›Paper›PMID 31619932›Full record

ArticleTurk pediatri arsivi2019

A rare cause of brachial plexopathy: hereditary neuralgic amyotrophy.

Hepsen Mine Serin, Sanem Yılmaz, Seda Kanmaz, Erdem Şimşek, Gül Aktan, Hasan Tekgül, Sarenur Gökben

Abstract readCase Reports
In one paragraph

Article in Turk pediatri arsivi, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Orphan Peripheral Neuropathies.Journal of neuromuscular diseases · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hepsen Mine SerinDivision of Pediatric Neurology, Department of Pediatrics, Ege University Faculty of Medicine, İzmir, Turkey.
Sanem YılmazDivision of Pediatric Neurology, Department of Pediatrics, Ege University Faculty of Medicine, İzmir, Turkey.
Seda KanmazDivision of Pediatric Neurology, Department of Pediatrics, Ege University Faculty of Medicine, İzmir, Turkey.
Erdem ŞimşekDivision of Pediatric Neurology, Department of Pediatrics, Ege University Faculty of Medicine, İzmir, Turkey.
Gül AktanDivision of Pediatric Neurology, Department of Pediatrics, Ege University Faculty of Medicine, İzmir, Turkey.
Hasan TekgülDivision of Pediatric Neurology, Department of Pediatrics, Ege University Faculty of Medicine, İzmir, Turkey.
Sarenur GökbenDivision of Pediatric Neurology, Department of Pediatrics, Ege University Faculty of Medicine, İzmir, Turkey.
Ege University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuralgic amyotrophy is characterized by recurrent, painful, unilateral neuropathy involving mainly the upper brachial plexus followed by muscle weakness and muscle wasting. There are two forms: idiopathic and hereditary. Hereditary neuralgic amyotrophy is an autosomal dominant disease that is often linked to a mutation of SEPT9, a gene of the Septin family. The phenotypic spectrum of the disease may include hypotelorism, cleft palate, and other minor dysmorphisms. The age of onset is from infancy to adulthood. Hereditary neuralgic amyotrophy can be triggered by external stimuli such as infections, vaccinations, cold, stress, surgery, and strenuous exercise. Here, we report a six-year-old girl who was found to have mutation in the SEPT9 gene when she presented with recurrent attacks of painful brachial plexopathy following vaccinations, and was diagnosed as having hereditary neuralgic amyotrophy.

Indexed as

Hereditary neuralgic amyotrophySEPT 9vaccination

Identifiers

PMID31619932
PMCPMC6776451
OpenAlexW2896006253

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.